Back
Spyre Therapeutics 10K Form
Sell
40
SYRE
Spyre Therapeutics
Last Price:
27.50
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SYRE News And Ratings
See the #1 stock for the next 7 days that we like better than SYRE
SYRE Financial Statistics
Sales & Book Value
| Annual Sales: | $886K |
|---|---|
| Cash Flow: | $-29.42M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.34 |
| Price / Book: | 8.59 |
Profitability
| EPS (TTM): | -5.17220 |
|---|---|
| Net Income (TTM): | $-214.9M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Spyre Therapeutics Earnings Forecast
Key Spyre Therapeutics Financial Ratios
- The Research & Development expenses have been 10,102.03% of Revenue.
- The Net Earning history of SYRE is -38,238.15% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 6 years.
Spyre Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SYRE |
| Website: | spyre.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SYRE Technical Analysis vs Fundamental Analysis
Sell
40
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a Sell
The current Spyre Therapeutics [SYRE] share price is $27.50. The Score for SYRE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.